Oneness Biotech Co., Ltd.

TPEX:4743 Lagerbericht

Marktkapitalisierung: NT$68.2b

Oneness Biotech Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Oneness Biotech is forecast to grow earnings and revenue by 11.4% and 18.9% per annum respectively while EPS is expected to grow by 11.5% per annum.

Wichtige Informationen

11.4%

Wachstumsrate der Gewinne

11.5%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum17.1%
Wachstumsrate der Einnahmen18.9%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert26 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Announcing: Oneness Biotech (GTSM:4743) Stock Soared An Exciting 936% In The Last Three Years

Mar 01
Announcing: Oneness Biotech (GTSM:4743) Stock Soared An Exciting 936% In The Last Three Years

Gewinn- und Umsatzwachstumsprognosen

TPEX:4743 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (TWD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2025137-793N/A-25,9831
12/31/2024119-706-3158,6681
6/30/2024102-979-421-343N/A
3/31/202490-1,141-402-307N/A
12/31/202387-1,313-513-422N/A
9/30/202376-1,469-880-772N/A
6/30/202371-967-909-823N/A
3/31/20231,068-293-1,028-944N/A
12/31/20221,066360-970-881N/A
9/30/20221,0691,131-724-648N/A
6/30/20221,079679-706-605N/A
3/31/202275-132-700-580N/A
12/31/202166-403-389-289N/A
9/30/202152-1,099-287-146N/A
6/30/202130-901-217-83N/A
3/31/20214964160314N/A
12/31/202042-2425158N/A
9/30/202039156-4652N/A
6/30/20204275-1272N/A
3/31/202013-481-229-186N/A
12/31/201913-322-261-213N/A
9/30/201916-202-88-10N/A
6/30/201915-255-94-2N/A
3/31/201916-209-11410N/A
12/31/201819-235-172-5N/A
9/30/201815-230-338-135N/A
6/30/201812-151-382-140N/A
3/31/201810-171N/A-157N/A
12/31/20173-155N/A-165N/A
9/30/20173-149N/A-176N/A
6/30/20174-34N/A-148N/A
3/31/20175-21N/A-128N/A
12/31/20166-14N/A-109N/A
9/30/20166-5N/A-96N/A
6/30/20165-106N/A-110N/A
3/31/20169-103N/A-139N/A
12/31/20158-93N/A-142N/A
9/30/20157-27N/A-120N/A
6/30/20158172N/A-145N/A
3/31/20155195N/A-157N/A
12/31/20145200N/A-151N/A
9/30/20145118N/A-167N/A
6/30/20144116N/A-130N/A
3/31/20144236N/A-93N/A
12/31/20135276N/A-89N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 4743 is forecast to remain unprofitable over the next 3 years.

Ertrag vs. Markt: 4743 is forecast to remain unprofitable over the next 3 years.

Hohe Wachstumserträge: 4743 is forecast to remain unprofitable over the next 3 years.

Einnahmen vs. Markt: 4743's revenue (18.9% per year) is forecast to grow faster than the TW market (11.7% per year).

Hohe Wachstumseinnahmen: 4743's revenue (18.9% per year) is forecast to grow slower than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Insufficient data to determine if 4743's Return on Equity is forecast to be high in 3 years time

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y